NASDAQ:ORKA

Oruka Therapeutics Stock Insider Trading

*Your capital is at risk

$57.20

+1.97 (+3.57%)

At Close: Jun 03, 2026

Oruka Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -30.36. In total, the insiders bought 2.32M and sold 184.39K ORKA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-30.36
● Buy	2.32M shares
● Sell	184.39K shares
60% Buy Activity Strong Negative Correlation
Sell Signal Medium Confidence May 21, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -30.36. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 15, 2026 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Jan 15, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	4 381 Value: $138.3K
Jan 15, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	2 619 Value: $84.4K
Jan 02, 2026 Buy	Common Stock M-Exempt	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	5 000 Value: $39.0K
Jan 02, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	8 748 Value: $246.4K
Jan 02, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	3 144 Value: $91.4K
Jan 02, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	1 108 Value: $33.0K
Jan 02, 2026 Buy	Employee Warrant (right to buy) M-Exempt	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	5 000 Value: $39.0K
Dec 19, 2025 Buy	Employee Stock Option (right to buy) M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Dec 19, 2025 Buy	Employee Warrant (right to buy) M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $27.3K
Dec 19, 2025 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $27.3K
Dec 19, 2025 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	641 Value: $18.3K
Dec 19, 2025 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	1 787 Value: $52.9K
Dec 19, 2025 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Dec 19, 2025 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	1 492 Value: $45.8K
Dec 19, 2025 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	3 080 Value: $97.3K
Dec 11, 2025 Buy	Stock Option (right to buy) A-Award	Martin Christopher Nathan Director	Director	35 000 Value: $1.06M
Dec 11, 2025 Buy	Common Stock J-Other	Martin Christopher Nathan	Director	0 Value: $0
Sep 17, 2025 Buy	Common Stock A-Award	Fairmount Funds Management Llc	Director	333 340 Value: $5.00M
Sep 17, 2025 Buy	Common Stock A-Award	Fairmount Funds Management Llc	Director	333 340 Value: $5.00M
Jul 01, 2025 Buy	Employee Stock Option (right to buy) A-Award	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	25 000 Value: $295.0K
Jul 01, 2025 Buy	Common Stock	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	0 Value: $0
Jul 01, 2025 Buy	Warrant (right to buy)	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	99 996 Value: $780.0K
Jul 01, 2025 Buy	Employee Stock Option (right to buy)	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	137 500 Value: $1.72M
Jul 01, 2025 Buy	Employee Stock Option (right to buy) A-Award	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	25 000 Value: $295.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks